Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1981 1
1984 1
1987 3
1989 1
1990 6
1992 5
1993 1
1994 1
1995 2
1996 3
1997 3
1998 2
1999 1
2000 4
2001 2
2002 8
2003 7
2004 10
2005 13
2006 16
2007 18
2008 13
2009 21
2010 22
2011 28
2012 38
2013 49
2014 70
2015 68
2016 71
2017 71
2018 95
2019 124
2020 166
2021 191
2022 228
2023 83

Text availability

Article attribute

Article type

Publication date

Search Results

1,273 results

Results by year

Filters applied: . Clear all
Page 1
Inhibition of METTL3 attenuates renal injury and inflammation by alleviating TAB3 m6A modifications via IGF2BP2-dependent mechanisms.
Wang JN, Wang F, Ke J, Li Z, Xu CH, Yang Q, Chen X, He XY, He Y, Suo XG, Li C, Yu JT, Jiang L, Ni WJ, Jin J, Liu MM, Shao W, Yang C, Gong Q, Chen HY, Li J, Wu YG, Meng XM. Wang JN, et al. Among authors: ke j. Sci Transl Med. 2022 Apr 13;14(640):eabk2709. doi: 10.1126/scitranslmed.abk2709. Epub 2022 Apr 13. Sci Transl Med. 2022. PMID: 35417191
Laparoscopic versus open pancreatoduodenectomy for pancreatic or periampullary tumours: a multicentre, open-label, randomised controlled trial.
Wang M, Li D, Chen R, Huang X, Li J, Liu Y, Liu J, Cheng W, Chen X, Zhao W, Li J, Tan Z, Huang H, Li D, Zhu F, Qin T, Ma J, Yu G, Zhou B, Zheng S, Tang Y, Han W, Meng L, Ke J, Feng F, Chen B, Yin X, Chen W, Ma H, Xu J, Liu Y, Lin R, Dong Y, Yu Y, Liu J, Zhang H, Qin R; Minimally Invasive Treatment Group in the Pancreatic Disease Branch of China's International Exchange and Promotion Association for Medicine and Healthcare (MITG-P-CPAM). Wang M, et al. Among authors: ke j. Lancet Gastroenterol Hepatol. 2021 Jun;6(6):438-447. doi: 10.1016/S2468-1253(21)00054-6. Epub 2021 Apr 27. Lancet Gastroenterol Hepatol. 2021. PMID: 33915091 Clinical Trial.
AAV-ie-K558R mediated cochlear gene therapy and hair cell regeneration.
Tao Y, Liu X, Yang L, Chu C, Tan F, Yu Z, Ke J, Li X, Zheng X, Zhao X, Qi J, Lin CP, Chai R, Zhong G, Wu H. Tao Y, et al. Among authors: ke j. Signal Transduct Target Ther. 2022 Apr 22;7(1):109. doi: 10.1038/s41392-022-00938-8. Signal Transduct Target Ther. 2022. PMID: 35449181 Free PMC article.
Ciliogenesis requires sphingolipid-dependent membrane and axoneme interaction.
Wu D, Huang J, Zhu H, Chen Z, Chai Y, Ke J, Lei K, Peng Z, Zhang R, Li X, Huang K, Li W, Zhao C, Ou G. Wu D, et al. Among authors: ke j. Proc Natl Acad Sci U S A. 2022 Aug 2;119(31):e2201096119. doi: 10.1073/pnas.2201096119. Epub 2022 Jul 27. Proc Natl Acad Sci U S A. 2022. PMID: 35895683 Free PMC article.
Trans-ethnic genome-wide association study of severe COVID-19.
Wu P, Ding L, Li X, Liu S, Cheng F, He Q, Xiao M, Wu P, Hou H, Jiang M, Long P, Wang H, Liu L, Qu M, Shi X, Jiang Q, Mo T, Ding W, Fu Y, Han S, Huo X, Zeng Y, Zhou Y, Zhang Q, Ke J, Xu X, Ni W, Shao Z, Wang J, Liu P, Li Z, Jin Y, Zheng F, Wang F, Liu L, Li W, Liu K, Peng R, Xu X, Lin Y, Gao H, Shi L, Geng Z, Mu X, Yan Y, Wang K, Wu D, Hao X, Cheng S, Qiu G, Guo H, Li K, Chen G, Sun Z, Lin X, Jin X, Wang F, Sun C, Wang C. Wu P, et al. Among authors: ke j. Commun Biol. 2021 Aug 31;4(1):1034. doi: 10.1038/s42003-021-02549-5. Commun Biol. 2021. PMID: 34465887 Free PMC article.
Efficacy of Huoxiang Zhengqi dropping pills and Lianhua Qingwen granules in treatment of COVID-19: A randomized controlled trial.
Xiao M, Tian J, Zhou Y, Xu X, Min X, Lv Y, Peng M, Zhang Y, Yan D, Lang S, Zhang Q, Fan A, Ke J, Li X, Liu B, Jiang M, Liu Q, Zhu J, Yang L, Zhu Z, Zeng K, Li C, Zheng Y, Wu H, Lin J, Lian F, Li X, Tong X. Xiao M, et al. Among authors: ke j. Pharmacol Res. 2020 Nov;161:105126. doi: 10.1016/j.phrs.2020.105126. Epub 2020 Aug 8. Pharmacol Res. 2020. PMID: 32781283 Free PMC article. Clinical Trial.
Fangchinoline inhibits non-small cell lung cancer metastasis by reversing epithelial-mesenchymal transition and suppressing the cytosolic ROS-related Akt-mTOR signaling pathway.
Chen B, Song Y, Zhan Y, Zhou S, Ke J, Ao W, Zhang Y, Liang Q, He M, Li S, Xie F, Huang H, Chan WN, Cheung AHK, Ma BBY, Kang W, To KF, Xiao J. Chen B, et al. Among authors: ke j. Cancer Lett. 2022 Sep 1;543:215783. doi: 10.1016/j.canlet.2022.215783. Epub 2022 Jun 11. Cancer Lett. 2022. PMID: 35700820
1,273 results